SPECTRA GROUP LIMITED, INC. — Department of Defense SBIR Phase II: Development and commercialization of advanced blood simulant system are proposed. The adv
SPECTRA GROUP LIMITED, INC. — SBIR Phase II award from Department of Defense.
- Amount
- $948,861
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Solicitation
- 2010.3
- NAICS
- —
- Place of performance
- OH
- Period
- 2012-04-15
Description
Development and commercialization of advanced blood simulant system are proposed. The advanced blood simulant will be non-biological and have realistic color, flow, and coagulation properties. The simulant will be developed in tandem with coagulation laminate. The testing will be performed using currently used training hemorrhage simulators. The new advanced blood simulant will be used in training exercises and presentations by military and civilian first responders. As the product will be formulated with waterbased components, it is expected to be inexpensive and easy to clean. The product is projected to have excellent stability and can be stored for years without decrease in level of performance. The product is expected to work with all currently used bleeding simulation systems.